1) Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007
2) Pignatti F, Bent M, Curran D, Debruyne C, Sylvester R, et al: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20: 2076-2084, 2002
3) Rosati A, Tomassini A, Pollo B, Ambrosi C, Schwarz A, et al: Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol 93: 395-400, 2009
4) Stockhammer F, Misch M, Helms HJ, Lengler U, Prall F, et al: IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure 21: 194-197, 2012
5) Huang L, You G, Jiang T, Li G, Li S, et al: Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study. J Neurol Sci 302: 63-67, 2011
FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol 13: 307-316, 2011
7) Sarkar C, Sinha S, Sharma MC, Kumar R, Mehta VS: Supratentorial glioblastoma in adults: identification of subsets and their clinical correlation. Brain Tumor Pathol 21: 7-12, 2004
8) Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, et al: Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Neuropathology 30: 392-400, 2010
9) 日本脳腫瘍病理学会: 脳腫瘍臨床病理カラーアトラス 第3版. 医学書院, 東京, 2009